Outsourced Drug Discovery Model Offers Several Advantages to Pharmaceutical Companies All Over the World Including Being Cost-Effective

 

Outsourced Drug Discovery


Pharmaceutical scientists estimate that more than 500 potential drug targets are identified in the world today. Advances in genomics and proteomics promise a quantum leap in the number of usable drug targets. However, most pharmaceutical companies struggle to validate these targets and optimize their leads. With the help of outsourcing companies, pharma companies can focus on their core competencies and exploit the expertise of specialized contract research organizations.

The Global Outsourced Drug Discovery Market was valued at US$ 20.7 billion in 2017, and is expected to witness a CAGR of 12.1% during the forecast period (2019 – 2026).

This new model has several advantages. For one, it is more cost-effective. Companies with large budgets can hire top-tier drug discovery firms that specialize in specific areas. These firms are often able to leverage their extensive expertise to challenge larger pharmaceutical conglomerates. Further, contract sales organizations can help start-ups reach the market without the hefty overhead of large pharmaceutical companies. The upside is that one can leverage the intellectual capital of a small group of people with significant experience and expertise.

Outsourced drug discovery allows pharmaceutical companies to focus on core competencies while minimizing overhead and risk. Pharma companies in Shanghai are experimenting with new outsourcing and risk-sharing models. Medicilon/MPI Preclinical Research in Shanghai, for example, is a joint venture that offers a more integrated approach to drug discovery. This could help companies protect blockbuster drugs from the patent cliff.

In-house experts focus on core competencies and other key areas of expertise, and outsourced companies utilize expert contract research organizations to help them identify and prioritize drug targets. Outsourced drug discovery companies make use of artificial intelligence (AI) and genomics software to design efficient computer-aided drug models. Pharmaceutical research can be more cost-effective when it utilizes the best of existing research. Using these approaches, companies can increase the efficacy and safety of their products, reduce their risk and maximize profits.

A culture of innovation is taking root across Asia. As the region develops its infrastructure for world-class R&D, the level of technical and leadership talent increases. Moreover, regulatory issues are becoming more transparent and uniform across countries. As a result, the balance of pharmaceutical investment is shifting from developed markets to developing regions. This will result in high-end drug discovery in Asia. In January 2022, Shanghai Fosun Pharmaceutical (Fosun Pharma) and Insilico Medicine entered into a collaboration agreement for advancing the drug discovery and development targeting various targets with the use of AI technology.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more